Technical Analysis for PGEN - Precigen, Inc.

Grade Last Price % Change Price Change
C 8.29 0.97% 0.08
PGEN closed up 0.49 percent on Thursday, April 22, 2021, on 78 percent of normal volume. It was able to find support at its 50 day moving average. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
Earnings due: May 4
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical PGEN trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.97%
Doji - Bearish? Reversal 0.97%
Stochastic Reached Overbought Strength 0.97%
Above Upper BB Strength 0.97%
Overbought Stochastic Strength 0.97%
Up 3 Days in a Row Strength 0.97%
Upper Bollinger Band Touch Strength 0.97%
Crossed Above 50 DMA Bullish 1.47%
Pocket Pivot Bullish Swing Setup 1.47%
Above Upper BB Strength 1.47%
Older End-of-Day Signals for PGEN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 2% 15 minutes ago
Rose Above Upper Bollinger Band 26 minutes ago
Up 1% 26 minutes ago
Rose Above Previous Day's High about 22 hours ago
Up 3% about 22 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Precigen, Inc. Description

Precigen, Inc. engages in the engineering and industrialization of biology in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that consist of key genetic components. It provides reproductive technologies and other genetic processes to cattle breeders and producers; biological insect control solutions; technologies for non-browning apple without the use of artificial additives; genetically engineered swine for medical and genetic research; commercial aquaculture products; and preservation and cloning technologies. The company also offers UltraVector platform that enables design and assembly of gene programs that facilitate control over the quality, function, and performance of living cells; and RheoSwitch inducible gene switch that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression. In addition, it provides AttSite Recombinases, which allows stable, targeted gene integration and expression; LEAP automated platform to identify and purify cells of interest, such as antibody expressing cells and stem cells; ActoBiotics platform for targeted in situ expression of proteins and peptides from engineered microbes; and AdenoVerse technology platform for tissue specificity and target selection. The company serves the health, food, energy, and environment markets. Precigen, Inc. has collaboration and license agreements with ZIOPHARM Oncology, Inc.; Ares Trading S.A.; Oragenics, Inc.; Intrexon T1D Partners, LLC; Intrexon Energy Partners, LLC; Intrexon Energy Partners II, LLC; Genopaver, LLC; Fibrocell Science, Inc.; Persea Bio, LLC; OvaXon, LLC; S & I Ophthalmic, LLC; Harvest start-up entities; and Surterra Wellness. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Emerging Technologies Stem Cells Molecular Biology Ophthalmic Gene Expression Peptides Genetic Engineering Cattle Control Solutions Aquaculture Biological Engineering Cloning Intrexon

Is PGEN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 11.1
52 Week Low 2.14
Average Volume 1,298,961
200-Day Moving Average 6.63
50-Day Moving Average 7.98
20-Day Moving Average 7.31
10-Day Moving Average 7.51
Average True Range 0.55
ADX 17.8
+DI 27.40
-DI 12.96
Chandelier Exit (Long, 3 ATRs ) 6.86
Chandelier Exit (Short, 3 ATRs ) 8.18
Upper Bollinger Band 8.22
Lower Bollinger Band 6.41
Percent B (%b) 1.0
BandWidth 24.69
MACD Line -0.02
MACD Signal Line -0.19
MACD Histogram 0.1688
Fundamentals Value
Market Cap 1.52 Billion
Num Shares 185 Million
EPS -2.09
Price-to-Earnings (P/E) Ratio -3.94
Price-to-Sales 13.18
Price-to-Book 26.10
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.09
Resistance 3 (R3) 9.10 8.81 8.94
Resistance 2 (R2) 8.81 8.59 8.81 8.89
Resistance 1 (R1) 8.51 8.45 8.66 8.50 8.84
Pivot Point 8.23 8.23 8.30 8.22 8.23
Support 1 (S1) 7.93 8.00 8.08 7.92 7.58
Support 2 (S2) 7.64 7.86 7.64 7.53
Support 3 (S3) 7.34 7.64 7.48
Support 4 (S4) 7.33